Jan Novotny

Title: Jan Novotny: Innovator in Pharmaceutical Chemistry

Introduction

Jan Novotny is a notable inventor based in Olomouc, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of various salts used in medications. With a total of 2 patents, his work has had a meaningful impact on the industry.

Latest Patents

One of his latest patents is titled "Method for the preparation of tizanidine hydrochloride." This invention focuses on a preparation method for salts of 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole (tizanidine), specifically tizanidine hydrochloride. The method involves preparing a salt of tizanidine and a carboxylic acid as an intermediate, which, after acidification with hydrogen chloride, yields tizanidine hydrochloride in high yield and purity.

Another significant patent is "Methods for the preparation of salts of 2-[2-(4-dibenzo[B,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxyl]ethanol (quetiapine) and for the purification thereof." This method describes the preparation of salts from the quetiapine base and the respective acid, where the salt is precipitated from a mixture of solvents. The salts of quetiapine are then purified through partial crystallization.

Career Highlights

Jan Novotny is currently employed at Farmak, a.s., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing methods that enhance the efficiency and purity of pharmaceutical compounds.

Collaborations

Throughout his career, Jan has collaborated with notable colleagues such as Pavel Hradil and Lubomir Kvapil. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Jan Novotny stands out as a significant figure in pharmaceutical innovation, with his patents reflecting his expertise and dedication to improving medication preparation methods. His contributions continue to influence the field positively.